by lythamcorp | Nov 13, 2024 | Healthcare, ImmuCell Corporation, ImmuCell News
PORTLAND, Maine, Nov. 13, 2024 — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the...
by lythamcorp | Nov 13, 2024 | Industrials, LiqTech, LiqTech News
BALLERUP, Denmark, Nov. 13, 2024 — LiqTech International, Inc. (NASDAQ: LIQT), a high-tech filtration technology company that manufactures and markets highly specialized filtration products and systems, today announced the receipt of an order from a leading...
by lythamcorp | Nov 13, 2024 | PolyPid, PolyPid News
Last Patient Enrolled for Planned Unblinded Interim Analysis in Ongoing SHIELD II Phase 3 Trial of D-PLEX100 Unblinded Interim Analysis Outcome Expected Later this Quarter SHIELD II Enrollment Completion Expected in December 2024 with Top-Line Results Anticipated in...
by lythamcorp | Nov 12, 2024 | Industrials, SenesTech, SenesTech News
Record Revenue and Margin Performance PHOENIX, Nov. 12, 2024 — SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”), the leader in fertility control to manage animal pest populations and the only manufacturer of commercial and...
by lythamcorp | Nov 12, 2024 | Healthcare, Scientific Industries, Scientific Industries News
Investor Call to be held at 11:00 AM Eastern TimeBOHEMIA, N.Y., Nov. 12, 2024 — Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced today it plans file the Form 10Q...